Abrahams Ocanto

Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 22, 2026

Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study.

Journal: Clinical and translational radiation oncology

Published: June 09, 2026

MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes.

Journal: Clinical and translational radiation oncology

Published: May 10, 2026

Correction: Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns‑of‑care survey by the SEOR‑GI Group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: April 13, 2026

Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges.

Journal: Archivos espanoles de urologia

Published: April 07, 2026

Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer.

Journal: Actas urologicas espanolas

Published: February 23, 2026

Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns-of-care survey by the SEOR-GI Group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: December 01, 2025

Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in Spain.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: November 12, 2025

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study.

Journal: Biomedicines

Published: July 18, 2025

Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.

Clinical outcomes of stereotactic body radiotherapy in oligometastatic disease: a national real-world cohort study.

Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study.

Early outcomes of online adaptive MR-guided SBRT for localized prostate cancer: a prospective study.

MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes.

MRI-guided adaptive stereotactic body radiotherapy for the prostate bed: a prospective study of safety, tolerability, and patient-reported quality-of-life outcomes.

Correction: Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns‑of‑care survey by the SEOR‑GI Group.

Correction: Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns‑of‑care survey by the SEOR‑GI Group.

Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges.

Adjuvant Radiotherapy After Cystectomy in Muscle-Invasive Bladder Cancer: Indications, Benefits and Remaining Challenges.

Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer.

Position paper of the Spanish Society of Radiotherapeutic Oncology (SEOR) and its genitourinary tumors group (URONCOR) on the prescription of parp inhibitors in advanced prostate cancer.

Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns-of-care survey by the SEOR-GI Group.

Total neoadjuvant therapy for locally advanced rectal cancer in Spain: results from a national patterns-of-care survey by the SEOR-GI Group.

Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in Spain.

Biochemical control and 2-year tolerability following stereotactic body radiotherapy for localized prostate cancer: a multicenter study in Spain.

Elective pelvic radiotherapy in prostate cancer: The sunset of a historical practice.

Elective pelvic radiotherapy in prostate cancer: The sunset of a historical practice.

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

Management of high-risk prostate cancer in Spain: results from a national patterns of care survey.

GnRH Antagonists: Current Evidence and Role in Prostate Cancer.

GnRH Antagonists: Current Evidence and Role in Prostate Cancer.

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study.

First Spanish Experience with Stereotactic MR-Guided Adaptive Radiotherapy (SMART) in Borderline Resectable and Locally Advanced Pancreatic Cancer: A Prospective Study.